Evidence map›Paper›PMID 34943974›Full record

ReviewCells2021

Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System.

Ruqaia Abbas, Sarit Larisch

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cul5bioRxiv : the preprint server for biology · 2025
    Article
  12. Review
  13. Article
  14. A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.Journal of experimental & clinical cancer research : CR · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ruqaia AbbasLaboratory of Cell Death and Cancer Research, Biology & Human Biology Departments, Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel.
Sarit LarischLaboratory of Cell Death and Cancer Research, Biology & Human Biology Departments, Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel.
University of Haifa · IL

Funding

Israel Science Foundation 1264/06Israel Science Foundation 822/12United States-Israel Binational Science Foundation 2003085
6 · The paper itself

Abstract

Apoptosis is a cell suicide process that is essential for development, tissue homeostasis and human health. Impaired apoptosis is associated with a variety of human diseases, including neurodegenerative disorders, autoimmunity and cancer. As the levels of pro- and anti-apoptotic proteins can determine the life or death of cells, tight regulation of these proteins is critical. The ubiquitin proteasome system (UPS) is essential for maintaining protein turnover, which can either trigger or inhibit apoptosis. In this review, we will describe the E3 ligases that regulate the levels of pro- and anti-apoptotic proteins and assisting proteins that regulate the levels of these E3 ligases. We will provide examples of apoptotic cell death modulations using the UPS, determined by positive and negative feedback loop reactions. Specifically, we will review how the stability of p53, Bcl-2 family members and IAPs (Inhibitor of Apoptosis proteins) are regulated upon initiation of apoptosis. As increased levels of oncogenes and decreased levels of tumor suppressor proteins can promote tumorigenesis, targeting these pathways offers opportunities to develop novel anti-cancer therapies, which act by recruiting the UPS for the effective and selective killing of cancer cells.

Indexed as

ApoptosisHumansInhibitor of Apoptosis ProteinsProteasome Endopeptidase ComplexProteolysisProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53UbiquitinUbiquitin-Protein LigasesBCL2 protein, humanInhibitor of Apoptosis ProteinsProteasome Endopeptidase ComplexProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53UbiquitinUbiquitin-Protein LigasesARTSBcl-2cIAPMcl-1MDM2p53parkinSmacubiquitin proteasome systemXIAP

Identifiers

PMID34943974
PMCPMC8700063
OpenAlexW4200123076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.